Inositol (Compound)

Synonyms:inositol, myo-inositol, Scyllo-inositol, epi-Inositol, Muco-Inositol, Allo-inositol, i-Inositol, 87-89-8, meso-Inositol, Neo-inositol, 1D-Chiro-inositol, 1L-Chiro-inositol, D-(+)-chiro-Inositol, cis-Inositol, 643-12-9, 488-59-5, D-chiro-Inositol, Myoinositol, Scyllitol, 6917-35-7, Cyclohexane-1,2,3,4,5,6-hexaol, cyclohexane-1,2,3,4,5,6-hexol, 488-58-4, Quercinitol, mesoinositol, Cocositol, 551-72-4, Meat sugar, Myoinosite, Dambose, chiro-inositol, Inositene, Inositina, L-chiro-Inositol, Phaseomannite, Inosital, Inosite, Iso-inositol, Cyclohexitol, Phaseomannitol, 41546-34-3, Inositol, myo-, Mesoinosit, Mesoinosite, Scyllite, Mesovit, Nucite, Mesol, 643-10-7, 488-55-1, Cyclohexanehexol, Inositol, meso-, cis-1,2,3,5-trans-4,6-Cyclohexanehexol, D-myo-Inositol, D-chiro Inositol, 488-54-0, Bios I, Insitolum, Isoinositol, L-(-)-chiro-Inositol, (-)-Inositol, 576-63-6, d-Inositol, L-Inositol, L-myo-Inositol, Inositol, allo-, Inositol, muco-, Inositol, i-, Inositol, scyllo-, Inositol (VAN), alloinositol, neoinositol, Hexahydroxycyclohexane, scyllo-Cyclohexanehexol, 1D-myo-Inositol, 1L-myo-Inositol, Inositol, cis-, Inositol, epi-, Inositol, neo-, epi-Cyclohexanehexol, (+)-Inositol, 1,2,3,4,5,6-Cyclohexanehexol, (-)-chiro-Inositol, ELND005, Rat antispectacled eye factor, Levoinositol, CCRIS 6745, 1,2,3,5-trans-4,6-Cyclohexanehexol, cis-, AZD 103, Chiro-inositol, (-)-, Inositol, myo, (1R,2R,3S,4R,5r,6S)-cyclohexane-1,2,3,4,5,6-hexaol, 38876-99-2, MFCD00077932, (1r,2r,3r,4r,5r,6r)-cyclohexane-1,2,3,4,5,6-hexol, 1,3,5/2,4,6-Hexahydroxycyclohexane, (1R,2R,3R,4R,5S,6S)-Cyclohexane-1,2,3,4,5,6-hexaol, (1R,2R,3S,4S,5S,6S)-Cyclohexane-1,2,3,4,5,6-hexaol, 1-L-chiro-Inositol, Inositol, D-chiro-, (+)-Chiro-Inositol, CHEBI:17268, AI3-16111, NSC8101, 1,3,5/2,4,6-cyclohexanehexol, 1,2,3,5/4,6-Cyclohexanehexol, NSC 8101, NSC-8101, Chiro-inositol, (+)-, (1r,2R,3S,4r,5R,6S)-cyclohexane-1,2,3,4,5,6-hexol, (1R,2R,3R,4S,5S,6s)-cyclohexane-1,2,3,4,5,6-hexaol, (1R,2R,3S,4S,5S,6S)-cyclohexane-1,2,3,4,5,6-hexol, 1,2,3,4,5,6-HEXAHYDROXY-CYCLOHEXANE, NSC-25142, NSC-55551, NSC404118, myo-Inositol;meso-Inositol, NSC 404118, NSC-404118, J101.890F, J101.891D, (1s,2s,3s,4s,5s,6s)-cyclohexane-1,2,3,4,5,6-hexol, 63GQX5QW03, 8LQ63P85IC, 9O6Y5O4P9W, ELND-005, R1Y9F3N15A, (1R,2R,3R,4R,5S,6S)-cyclohexane-1,2,3,4,5,6-hexol, (1r,2R,3R,4s,5S,6S)-cyclohexane-1,2,3,4,5,6-hexol, (1s,2R,3R,4s,5S,6S)-cyclohexane-1,2,3,4,5,6-hexol, DTXSID7023146, CHEBI:10642, CHEBI:23927, CHEBI:27372, CHEBI:27987, AZD-103, 4661D3JP8D, 6R79WV4R10, M94176HJ2F, Inositol (VAN8C, NSC45517, NSC55551, NSC55552, NSC-55552, NSC-55558, 1VS4X81277, NSC-103959, NSC-127230, INS, NCGC00159409-02, (1R,2R,3S,4R,5S,6S)-cyclohexane-1,2,3,4,5,6-hexaol, (1R,2R,3S,4R,5S,6S)-cyclohexane-1,2,3,4,5,6-hexol, (1r,2R,3S,4s,5R,6S)-cyclohexane-1,2,3,4,5,6-hexol, 4L6452S749, 587A93P465, Inositol, myo- (8CI), MYO-INOSITOL-1,2,3,4,5,6-D6, 1,3,4,5,6-Cyclohexanehexol, 1,3,5/4,6-Cyclohexanehexol, DTXCID2065254, 1,2,4/3,5,6-cyclohexanehexol, rel-(1r,2r,3r,4r,5r,6r)-Cyclohexane-1,2,3,4,5,6-hexaol, rel-(1R,2r,3S,4R,5s,6S)-Cyclohexane-1,2,3,4,5,6-hexaol, Mouse antialopecia factor, 1,2,3,4,5,6-Cyclohexanehexol #, cis-1,2,3,4,5,6-cyclohexanehexol, CAS-87-89-8, cis-1,3,5-trans-4,6-Cyclohexanehexol, SMR000857145, SMR000857319, SMR000857320, Inositol NF 12, ELND 005, SR-05000001655, EINECS 201-781-2, MFCD00065455, 1,2,3,4,5,6-Hexahydroxycyclohexane, inositols, UNII-63GQX5QW03, UNII-8LQ63P85IC, UNII-9O6Y5O4P9W, UNII-R1Y9F3N15A, an inositol, Inositol [Nonspecific isomer], UNII-4661D3JP8D, UNII-6R79WV4R10, UNII-M94176HJ2F, Muscle sugar, inositol myo-, D-muco-Inositol, UNII-1VS4X81277, Inositol FCC, 4irx, Inositol, chiro-, rac-chiro-inositol, UNII-4L6452S749, UNII-587A93P465, Inosital (TN), Inositol (NF), CBU, EINECS 207-681-5, EINECS 207-682-0, EINECS 209-000-7, EINECS 211-393-5, EINECS 211-394-0, EINECS 230-024-9, NSC 25142, EPIINOSITOL, (+)-Epi-Inositol, CHIRO-INOSITOLS, Epi-inositol, 98%, allo-Inositol, 97%, Inositol [USAN:NF], INOSITOL, MESO, Spectrum_001595, 2os9, INOSITOL [INCI], INOSITOL [USAN], INOSITOL [FCC], INOSITOL [INN], orthorhombic myo-inositol, D-(+)-Chiro Inositol, DL-CHIRO-INOSITOL, INOSITOL [MI], INOSITOL (D), INOSITOL (L), INOSITOL [VANDF], Spectrum3_001053, Spectrum4_001193, Spectrum5_000961, myo-Inositol, >=99%, INOSITOL [MART.], bmse000102, bmse000103, bmse000113, bmse000901, bmse000922, Epitope ID:144993, INOSITOL [USP-RS], INOSITOL [WHO-DD], scyllo-Inositol, >=98%, SCHEMBL5831, SCHEMBL5832, SCHEMBL5969, NCIOpen2_008191, BSPBio_002606, KBioGR_001885, KBioSS_002075, MLS001332377, MLS001332378, MLS001335965, MLS001335966, MLS001335967, MLS001335968, SCHEMBL187278, SCHEMBL187397, SCHEMBL187796, SCHEMBL188106, SCHEMBL188237, SCHEMBL491333, SCHEMBL959404, SCHEMBL959405, CHEMBL278373, CHEMBL468154, GTPL4495, GTPL4645, GTPL4648, GTPL4649, MEGxp0_001817, SCHEMBL1055883, SCHEMBL4748543, SCHEMBL6378921, SCHEMBL6468882, SCHEMBL6791918, CHEMBL1222251, CHEMBL1231671, CHEMBL1950780, CHEMBL3976780, SCHEMBL12371461, SCHEMBL12377889, SCHEMBL12411898, SCHEMBL12711208, SCHEMBL12735687, SCHEMBL13058696, SCHEMBL13114115, SCHEMBL13114116, SCHEMBL13114128, SCHEMBL13207905, SCHEMBL13580047, SCHEMBL14542470, SCHEMBL21388397, ACon1_002457, CHEBI:22357, CHEBI:23311, CHEBI:24848, CHEBI:25492, CHEBI:27374, D-(+)-chiro-Inositol, 95%, KBio2_002075, KBio2_004643, KBio2_007211, KBio3_001826, L-(-)-chiro-Inositol, 95%, DTXSID30110000, DTXSID50905091, myo-Inositol, p.a., 98.0%, 1,2,3,4,5/6-cyclohexanehexol, 1,2,3,4/5,6-cyclohexanehexol, 1,2,3/4,5,6-cyclohexanehexol, 1,2,4,5/3,6-cyclohexanehexol, DTXSID101028818, DTXSID101028820, DTXSID201028823, DTXSID301028826, DTXSID601028825, DTXSID901028824, HMS2091N13, HMS2230N03, HMS2235H05, HMS2235M23, HMS3369B06, HMS3369F20, HMS3373E05, Pharmakon1600-01500352, D-CHIRO-INOSITOL [USP-RS], D-CHIRO-INOSITOL [WHO-DD], 1,2,3,4,5,6-Cyclohexanehexaol, BCP25172, HY-B1411, HY-N3021, MYO-INOSITOL [EP MONOGRAPH], NSC25142, NSC55558, D-myo-Inositol, Cell Culture Grade, Tox21_111642, Tox21_302035, CCG-36096, cis-Inositol, >=98.0% (TLC), MFCD00003863, MFCD00272608, MFCD00799555, MFCD00799556, MFCD01321249, NSC 55552, NSC 55558, NSC-45517, NSC103959, NSC127230, NSC757076, s4530, STL453612, epi-Inositol, >=98.0% (HPLC), 1,2,3,4,5,6/0-cyclohexanetetrol, AKOS006240678, AKOS006332036, AKOS015895894, AKOS015912905, AKOS015912934, AKOS015960429, AKOS015960633, AKOS015994742, AKOS024318869, Tox21_111642_1, CS-4782, CS-W010757, CS-W017225, DB03106, DB13178, DB15350, HY-W010041, HY-W016509, HY-W021265, HY-W127726, J9.771C, KS-1284, KS-1420, NSC 103959, NSC 127230, NSC-757076, SB44732, SB45039, SB46764, SB46855, D-chiro-Inositol, >=98.0% (HPLC), NCGC00159409-03, NCGC00159409-04, NCGC00169828-01, NCGC00178580-01, NCGC00178580-03, NCGC00255362-01, AC-11070, AS-10616, AS-68396, AS-68424, cyclohexane-1R,2R,3S,4S,5R,6S-hexol, LS-13189, NCI60_041778, SY060836, myo-Inositol, purum, >=98.0% (HPLC), rac-chiro-1,2,3,4,5,6-cyclohexanehexol, SBI-0051369.P003, cis-1,2,4-trans-3,5,6-Cyclohexanehexol, DB-051583, DB-051584, DB-054642, HY-121962, J101.888D, J101.889B, J101.892B, myo-Inositol, for microbiology, >=99.0%, CS-0023004, CS-0083766, CS-0369552, FT-0627237, FT-0632208, FT-0632209, FT-0632730, FT-0652045, FT-0670351, FT-0670357, FT-0693444, FT-0693614, I0040, I0628, I0629, I0630, I0631, I0632, I0633, S6176, EN300-82941, myo-Inositol, BioUltra, >=99.5% (HPLC), myo-Inositol, SAJ special grade, >=99.0%, myo-Inositol, Vetec(TM) reagent grade, 99%, C00137, C06151, C06152, C06153, C19891, D08079, D78450, D91187, D91188, D91189, E78671, EN300-658805, F19572, I-6500, M01914, T72516, AB00051982_13, EN300-7361851, EN300-7411506, A834712, A836375, A866896, EN300-19631206, EN300-19632288, EN300-25914216, Q407997, Q743661, Q-201583, Q2838375, Q2974313, Q3011024, Q3023527, Q3205874, Q3331426, Q3347078, Q3589114, SR-05000001655-1, SR-05000001655-5, W-202861, W-202862, W-203081, W-203168, W-203392, 1,2,4/3,5,6-Cyclohexane-1,2,3,4,5,6-hexol, 7B0CEF84-D9CE-4A88-AA7D-EC50C89387A5, 1D7A27BF-6060-4FA9-AC46-3BD18DBA406E, 220128F1-89BF-442D-AD6D-E6D1EA7BA625, Z1486007281, (1r,2r,3r,4r,5r,6r)-cyclohexane-1,2,3,4,5,6-hexaol, (1R,2S,3r,4R,5S,6r)-cyclohexane-1,2,3,4,5,6-hexol, (1R,2S,3r,4R,5S,6s)-cyclohexane-1,2,3,4,5,6-hexol, (1R,2S,3s,4R,5S,6s)-cyclohexane-1,2,3,4,5,6-hexol, D-MYO-INOSITOL-1,2,5,6-TETRAPHOSPHATE SODIUM SALT, Inositol, United States Pharmacopeia (USP) Reference Standard, myo-Inositol, European Pharmacopoeia (EP) Reference Standard, (1R,2R,3S,4S,5S,6R)-CYCLOHEXANE-1,2,3,4,5,6-HEXOL, 1,2,3,4,5,6-Cyclohexanehexol, (cis,cis,cis,trans,cis,trans)- #, 1,2,3,4,5,6-cyclohexanehexol, (1alpha,2alpha,3alpha,4beta,5alpha,6beta), Inositol, Pharmaceutical Secondary Standard; Certified Reference Material, 1.ALPHA.,2.ALPHA.,3.BETA.,4.ALPHA.,5.BETA.,6.BETA.-CYCLOHEXANEHEXOL, 2H3, myo-Inositol, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture
Pubchem:PUBCHEM:892
Id:1fd737af-b781-5e6e-b929-e9c7520f1e21
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Inositol's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Inositol.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Inositol.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.